Cargando…

MON-532 Urinary Calcium Indices in Primary Hyperparathyroidism (PHPT) and Familial Hypocalciuric Hypercalcaemia (FHH): Is There a Need for Better Discrimination?

Introduction: Primary hyperparathyroidism (PHPT) has a prevalence of around 1% and requires surgery for definite treatment. On the other hand, familial hypocalciuric hypercalcaemia (FHH) is much rarer and does not need specific treatment. There may be considerable overlap in biochemical features in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arshad, Muhammad Fahad, McAllister, James, Merchant, Azhar, Rab, Edmund, Cook, Jacqueline, Eastell, Richard, Balasubramanian, Saba
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Bone and Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550810/ http://dx.doi.org/10.1210/js.2019-MON-532

Ejemplares similares

SAT-404 Neonatal Hypocalcemic Seizures in Offspring of a Mother with Familial Hypocalciuric Hypercalcemia Type 1 (FHH1)
por: Hannan, Fadil M, et al.
Publicado: (2020)

MON-539 Mice Harboring a Germline Heterozygous AP2S1 Mutation, Arg15Leu, Are a Model for Familial Hypocalciuric Hypercalcemia Type 3 (FHH3)
por: Hannan, Fadil, et al.
Publicado: (2019)

SAT-504 Role of Genetic Screening for FHH in a Patient with Hypercalcemia and Hyperparathyroidism
por: Caldwell, Laura, et al.
Publicado: (2019)

ODP099 Hyperparathyroidism Causing life Threatening Hypercalcaemia in Pregnancy
por: Lee, Jessica, et al.
Publicado: (2022)

SAT-369 Parathyroid Microadenomas as a Cause of Normocalcemic Primary Hyperparathyroidism (PHPT) and a Surgical Challenge
por: Nguyen, Tiffany, et al.
Publicado: (2020)

FRI687 Clinical Relevance Of 24-hour Urine Calcium Measurement In Patients With Primary Hyperparathyroidism (PHPT)
por: Bhan, Arti, et al.
Publicado: (2023)

MON-540 Familial Hypocalciuric Hypercalcemia Diagnosed in a 63-Year-Old Female
por: Mudgal, Mayuri, et al.
Publicado: (2019)

SAT180 Comparison Between Sporadic Primary Hyperparathyroidism And Multiple Endocrine Neoplasia Type 1 (MEN1)-Associated Primary Hyperparathyroidism: A Retrospective Analysis Of The Indian PHPT Registry
por: Bhadada, Sanjay, et al.
Publicado: (2023)

SAT182 Effects Of An Orally Bioavailable Nonpeptide Parathyroid Hormone Receptor Type 1 (PTH1R) Antagonist In Rodent Models Of Primary Hyperparathyroidism (PHPT)
por: Antwan, Agnes S, et al.
Publicado: (2023)

MON-376 Head to Toe Hyperparathyroidism - Impending Hyperparathyroid Crisis and Subsequent Crystal Arthropathies
por: Thomson, Alastair, et al.
Publicado: (2020)

MON-541 Successful Treatment of Normocalcemic Hyperparathyroidism in Children
por: Papadimitriou, Dimitrios, et al.
Publicado: (2019)

The Importance of Interpreting Urine Calcium:Creatinine Ratio in PHPT Within Ethnic Context
por: Abdel-Malek, Mariana, et al.
Publicado: (2021)

Atypical Presentation of Familial Hypocalciuric Hypercalcemia: Case Report
por: Ali, Dalal S, et al.
Publicado: (2021)

MON-368 A Case of Uremic Tumoral Calcinosis with Secondary Hyperparathyroidism
por: Mathew, Justin, et al.
Publicado: (2020)

MON-339 Secondary Hyperparathyroidism Due to Decrease 1 Alpha Hydroxylase Activity
por: Bahlol, Maimoona, et al.
Publicado: (2020)

MON-344 Uncommon Etiology of Hypophosphatemia and Secondary Hyperparathyroidism: Ferric Carboxymaltose Infusion
por: Sever, Sakine
Publicado: (2020)

MON-533 Irisin in Post-Menopausal Women with Primary Hyperparathyroidism: An Interplay between Irisin and Pth
por: Palermo, Andrea, et al.
Publicado: (2019)

SUN-LB088 Octreotide Induced Hypocalcemia in Case of Familial Hypocalciuric Hypercalcemia
por: Alkhazaali, Ali, et al.
Publicado: (2019)

MON-LB085 Blurred Vision and Hypocalcemia after Denosumab Injection in a Patient with Tertiary Hyperparathyroidism
por: Lim, Jayoung, et al.
Publicado: (2019)

MON-347 Osteitis Fibrosa Cystica and Pathological Fractures: The Classic but Neglected Skeletal Manifestation of Primary Hyperparathyroidism
por: Sirinvaravong, Sirinart, et al.
Publicado: (2020)

MON-336 Presumed Parathyroid Infarction Leading to Remission of Primary Hyperparathyroidism: A Rare Clinical Occurrence
por: Nguyen, Tiffany, et al.
Publicado: (2020)

MON-388 Total and Free 1,25dihydroxyvitamin D Levels in Postmenopausal Patients with Primary Hyperparathyroidism
por: Meng, Lingqiong, et al.
Publicado: (2020)

MON-LB64 Primary Hyperparathyroidism With Severe Hypercalcemia During Pregnancy: A Challenging Diagnosis and Management
por: George, Gemy M, et al.
Publicado: (2020)

SAT-361 Familial Hypocalciuric Hypercalcemia Type 3: AP2S1 Mutation
por: Kerut, Sarah Elizabeth, et al.
Publicado: (2020)

ODP128 Unusually High Serum Calcium in a Patient with Familial Hypocalciuric Hypercalcemia
por: Spiro, Andrew J, et al.
Publicado: (2022)

MON-537 Fusion of Parathyroid Hormone to Growth Hormone Binding Protein Delays Clearance Whilst Retaining Biological Activity
por: Wilkinson, Ian, et al.
Publicado: (2019)

PSAT173 Weekly Supplementation with Vitamin D3 reduces 1,25(OH)2 vitamin D3 Measured by Mass Spectrometry, and increases Fibroblast-like growth factor 23 (FGF23) in Individuals with and without Primary Hyperparathyroidism (PHPT)
por: Sidana, Shivani, et al.
Publicado: (2022)

MON-LB089 Preoperative Localization of Parathyroid Adenoma with Sonography and 99mtc-sestamibi Scintigraphy in Primary Hyperparathyroidism
por: Castro, Raquel, et al.
Publicado: (2019)

MON-346 Secondary Hyperparathyroidism and Other Complications in a Post-Roux-En-Y Patient: A Case Report
por: Chan, Jessica Michelle, et al.
Publicado: (2020)

ODP110 Parathyroid Hormone Independent Hypercalcaemia Secondary to Granulomatous Inflammation: Could This Be Melioidosis?
por: Grace, Samuel, et al.
Publicado: (2022)

SAT-532 Bisphosphonates Prevent Bone Loss Associated with Denosumab Treatment Discontinuation
por: Zanchetta, Maria Belen, et al.
Publicado: (2019)

MON-357 Craniofacial Deformities with Hypercalcemia: A Rare Case of Co-Existing Primary Hyperparathyroidism and Paget’s Disease of the Bone Since Young Adulthood
por: Nagaratnam, Shamharini, et al.
Publicado: (2020)

A novel CASR variant in a family with familial hypocalciuric hypercalcaemia and primary hyperparathyroidism
por: Sagi, Satyanarayana V, et al.
Publicado: (2020)

SAT-508 A Case Report Of Severe Hypercalcaemia Due To Iatrogenic (oral Supplements), Aki And Immobility
por: Khan, Inamullah, et al.
Publicado: (2019)

Type 1 Familial Hypocalciuric Hypercalcemia Caused by p.M74L Variant in the Calcium Sensing Receptor (CASR) Gene
por: Antony, McAnto, et al.
Publicado: (2021)

Clinical Presentation and Management Approach in a Case of Familial Hypocalciuric Hypercalcemia Type 3 Due to APS21 Gene Mutation
por: Elsheikh, Sahar A, et al.
Publicado: (2021)

SAT-351 A Novel Mutation in the Calcium-Sensing Receptor Gene Presenting in a Kindred as Autosomal Dominant Familial Hypocalciuric Hypercalcemia
por: Bushman, Jordan, et al.
Publicado: (2020)

SAT-340 Familial Hypocalciuric Hypercalcemia Due to a C.571G>A (p.Glu191Lys) Variant in the GNA11 Gene
por: Jeng, Henry Shiheng, et al.
Publicado: (2020)

SUN-532 Interferon Gamma-1b Does Not Increase Markers of Bone Resorption in Autosomal Dominant Osteopetrosis
por: Imel, Erik, et al.
Publicado: (2019)

SAT-506 Identification of a Mutation in AP2S1 Causing Familial Hypocalciuric Hypercalcemia Type 3 in a Patient with Unknown Family History of the Disease
por: Bhanot, Monica, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l8d95k2ftn2cq2ev8r9papajlq